Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: Outcome of diabetic patients in the AWESOME randomized trial and registry

Journal of the American College of Cardiology

Volumn 40, Issue 9, 2002, Pages 1555-1566

  Sedlis, Steven P ^a   Morrison, Douglass A ^b   Lorin, Jeffrey D ^a   Esposito, Rick ^a   Sethi, Gulshan ^b   Sacks, Jerome ^c   Henderson, William ^c   Grover, Frederick ^a   Ramanathan, K B ^d   Weiman, Darryl ^d   Saucedo, Jorge ^e   Antakli, Tamim ^e   Paramesh, Venki ^b   Pett, Stuart ^f   Vernon, Sarah ^f   Birjiniuk, Vladimir ^g   Welt, Frederick ^g   Krucoff, Mitchell ^h   Wolfe, Walter ^h   Lucke, John C ^a   Mediratta, Sundeep ^a   Booth, David ⁱ   Murphy, Edward ^j   Ward, Herbert ^k   Miller, LaWayne ^a   Kiesz, Stefan ^a   Barbiere, Charles ^a   Lewis, Dan ^a   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^c Research Service (151)   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^f VA Medical Center   (United States)

^g VA BOSTON HEALTHCARE SYSTEM   (United States)

^h DURHAM VA MEDICAL CENTER   (United States)

ⁱ LEXINGTON VA MEDICAL CENTER   (United States)

^j PORTLAND VA MEDICAL CENTER   (United States)

^k VA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; GERIATRIC PATIENT; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE-FREE SURVIVAL; HUMANS; PATIENT SELECTION; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037032259     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02346-X     Document Type: Article

References (50)

1. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: The Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
2. CABRI Trial Participants. First year results of CABRI (Coronary Angioplasty vs Bypass Revascularization Investigation). Lancet 1995; 346:1179-84.
3. King SB, Lembo NJ, Kosinski AS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-50.
4. Hamm CW, Riemers J, Ischinger T, et al. A randomized study of coronary, angioplasty compared with bypass surgery in patients with symptomatic multi-vessel coronary disease. N Engl J Med 1994;331: 1037-43.
5. Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multi-vessel disease (ERACI): In-hospital results and 1 year follow-up. J Am Coll Cardiol 1993;22:1060-7.
6. BARI Investigators. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 1991;84 Suppl 5:1-27.
7. Frye RL, King SB III, Sopko G, Detre KM, editors. A symposium: Multi-vessel PTCA versus CABG: Baseline data from the Bypass Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty Surgery Trial (EAST). Am J Cardiol 1995;75: 1c-59c.
8. Pocock SJ, Henderson RA, Rickards AF, et al. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
9. Sim I, Gupta M, McDonald K, Bourassa M, Hlatky MA. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multi-vessel coronary artery disease. Am J Cardiol 1995;76:1025-9.
10. Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results. J Am Coll Cardiol 2001;37:51-8.
11. Ryan TJ. Editorial: A randomized comparison with a different focus and a new result. J Am Coll Cardiol 2001;37:59-62.
12. BARI Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-25.
13. BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-9.
14. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 31:10-9.
15. Committee to revise the 1991 guidelines for Coronary Artery Bypass Graft Surgery. ACC/AHA guidelines for coronary artery bypass graft surgery. J Am Coll Cardiol 1999;34:1263-347.
16. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2000;36:970- 1062.
17. Barsness GW, Peterson ED, Ohman EM, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997;96:2551-6.
18. Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-40.
19. Morrison DA, Sethi G, Sacks J, et al. A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. Controlled Clin Trials 1999;20: 601-19.
20. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: A multicenter, randomized trial. J Am Coll Cardiol 2001;38:143-9.
21. Morrison DA, Sethi G, Sacks J, et al. A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The VA AWESOME Multicenter Registry: Comparison with the randomized clinical trial. J Am Coll Cardiol 2002;39:266-73.
22. Kirklin JW, Akins CW, Blackstone EH, et al. ACC/AHA task force report: Guidelines and indications for coronary artery bypass graft surgery. J Am Coll Cardiol 1991;17:543-89.
23. Edwards FH, Grover FL, Shroyer AL, Schwartz M, Bero J. The Society of Thoracic Surgeons National Cardiac Surgery Database: Current risk assessment. Ann Thorac Surg 1997;63:903-8.
24. Hannan EL, Racz MJ, McCallister BD, et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999;33:63-72.
25. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: A clinical severity score. JAMA 1992;267:2344-8.
26. Parsonnet V, Bernstein AD, Gera M. Clinical usefulness of risk-stratified outcome analysis in cardiac surgery in New Jersey. Ann Thorac Surg 1996;61 Suppl:S8-11.
27. Shroyer AL, Plomondon ME, Grover FL, Edwards FH. The 1996 coronary artery bypass risk model: The Society of Thoracic Surgeons Adult Cardiac National Database. Ann Thorac Surg 1999;67: 1205-8.
28. Hammermeister KE, Burchfiel C, Johnson R, Grover FL. Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990;82 Suppl:IV380-9.
29. Hammermeister KE, Johnson R, Marshall G, Grover FL. Continuous assessment and improvement in quality of care: A model from the Department of Veterans Affairs Cardiac Surgery. Ann Surg 1994;219: 281-90.
30. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
31. Milano CA, Kesler K, Archibald N, Sexton DJ, Jones RH. Mediastinitis after coronary artery bypass graft surgery: Risk factors and long-term survival. Circulation 1995;92:2245-51.
32. Slaughter MS, Olson MM, Lee JTJ, Ward HB. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thorac Surg 2001;56:1063-8.
33. Spelman DW, Russo P, Harrington G, Davis BB, Rabinov M, Smith JA, et al. Risk factors for surgical wound infection and bacteraemia following coronary artery bypass surgery. Aust N Z J Surg 2000;70: 47-51.
34. MacLeod KM, Tooke JE. Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes. Pharmacoeconomics 1995;8 Suppl 1:46-51.
35. Lazar HL, Fitzgerald C, Gross S, Heeren T, Aldea GS, Shemin RJ. Determinants of length of stay after coronary artery bypass graft surgery. Circulation 1995;92 Suppl:1120-4.
36. Mauldin PD, Becker ER, Phillips VL, Weintraub WS. Hospital resource utilization during coronary artery bypass surgery. J Interv Cardiol 1994;7:379-84.
37. Stewart RD, Lahey SJ, Levitsky S, Sanchez C, Campos CT. Clinical and economic impact of diabetes following coronary artery bypass. J Surg Res 1998;76:124-30.
38. Stewart RD, Campos CT, Jennings B, Lollis SS, Levitsky S, Lahey SJ. Predictors of 30-day hospital readmission after coronary artery bypass. Ann Thorac Surg 2000;70:169-74.
39. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-9.
40. Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998;32:1866-73.
41. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000;35:922-8.
42. The Epic Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1997;330:956-61.
43. The Epilog Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
44. The Epistent investigators. (Evaluation of platelet glycoprotein IIb/ IIIa inhibitor for stenting). Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998;352:87-92.
45. Detre KM, Lombardero MS, Brooks MM, et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000;342: 989-97.
46. Zuanetti G, Latini R, Maggioni AP, Franzosi M, Santoro L, Tognoni G. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: Data from the GISSI-3 study. Circulation 1997;96:4239-45.
47. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 1997;314:1512-5.
48. Shindler DM, Palmeri ST, Antonelli TA, et al. Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: A report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 2000;36 Suppl A:1097-103.
49. Marso SP, Lincoff AM, Ellis SG, et al. Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: Results of the EPISTENT (Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial) diabetic substudy. Circulation 1999;100:2477-84.
50. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: Insights for the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation 2001;104:553-8